Literature DB >> 7660080

Capnocytophaga (Capnocytophaga ochracea group) bacteremia in hematological patients with profound granulocytopenia.

B Kristensen1, H C Schønheyder, N A Peterslund, S Rosthøj, N Clausen, W Frederiksen.   

Abstract

The clinical and microbiological features of 7 cases of bacteremia due to Capnocytophaga (Capnocytophaga ochracea group) are reported. They were diagnosed during 1991-93 at three hospital clinics. Five patients were < 10 years old and all had hematological disorders, 4 acute lymphoblastic leukemia and 1 each had aplastic anemia, non-Hodgkin lymphoma, and myelodysplastic syndrome. All were profoundly granulocytopenic with an absolute granulocyte count < 0.13 x 10(9)/l, and all but 1 had oral lesions as a possible portal of entry. A favourable response to antibiotic therapy was recorded in all patients but one who, being profoundly granulocytopenic, rapidly succumbed to Pseudomonas aeruginosa septicemia. None of the isolates were beta-lactamase producers. In addition to penicillin the isolates were susceptible to broad-spectrum cephalosporins and ciprofloxacin, but resistant to aminoglycosides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7660080     DOI: 10.3109/00365549509018997

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

1.  Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides.

Authors:  A Rosenau; B Cattier; N Gousset; P Harriau; A Philippon; R Quentin
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Capnocytophaga bacteremia in a girl with relapsed acute lymphoblastic leukemia.

Authors:  Taha Khattab; Sami Felimban; Basheer Ahmed; Abdullah Zayed; Abimbola Osoba; David Baker
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

Review 3.  GINGIVAL ULCERATIONS IN A PATIENT WITH ACUTE MYELOID LEUKEMIA: A case report and literature review.

Authors:  Vanja Vučićević Boras; Danica Vidović Juras; Igor Aurer; Sandra Bašić-Kinda; Mirta Mikulić
Journal:  Acta Clin Croat       Date:  2019-09       Impact factor: 0.780

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.